Correction: Association of the Plasma and Tissue Riboflavin Levels with C20orf54 Expression in Cervical Lesions and Its Relationship to HPV16 Infection

In the first paragraph of the Results section, there is an error in the penultimate sentence. Please see the corrected sentence below:

“The average blood riboflavin level in high tumor stage patients ( ≥IIb) was 182.01±89.43 ug/L, which was significantly lower than in patients with low tumor stage ≤IIa(277.25±34.56 ug/L)."

There is an error in the Figure 3 legend. Please see the figure and the corrected legend below:

Figure 3. higher-expression of C20orf54 was detected in CSCC tissue by Western blot (A) and qRT-PCR (B).

A, Representative results of C20orf54 and β-tubulin protein was described in CSCC (T) and matched normal tissues (N) by western blot. B, Representative results of C20orf54 and β-actin mRNA was examined in CSCC (T) and corresponding normal tissues (N) by qRT-PCR. C, Box plot, the expression of C20orf54 mRNA was significantly higher in CSCC than that matched tissue(0.21±0.14 vs 0.16±0.12; n  =  22, P<0.05). D, Bar chart for relative expression of C20orf54 protein in CSCC and matched tissue (0.93± 0.41 vs 0.80±0.36; n  =  22) repeat three times in each sample,* indicates P<0.05, ☆indicates P<0.01).